AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 32291210
Drug: Clozapine treatment
RxNorm normalized name: Clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clozapine treatment (phase 3)
Trial: 32291210
Drug: 4-week treatment
RxNorm normalized name: milnacipran
DrugBank: Milnacipran (DB04896)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-week treatment
Trial: 32500827
Drug: Multi-strain probiotic
RxNorm normalized name: Digestive Advantage Multi-Strain Probiotic Ultra Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-strain probiotic supplementation (2 capsules daily for six months)
Trial: 33530822
Drug: Relocation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relocation of intravenous pumps from bedside to outside the patient room using extension tubing
Trial: 34752941
Drug: Two ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two ketamine infusions (n=30; days 1 and 4)
Trial: 34752941
Drug: Single ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single ketamine infusion (n=24; only day 1)
Trial: 34752941
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline placebo infusion (n=24; only day 1)
Trial: 34531554
Drug: Intrapolyp triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrapolyp triamcinolone acetonide (TA) injection (20 mg/ml, 2 mL)
Trial: 34531554
Drug: Placebo normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo normal saline injection (2 mL)
Trial: 32488332
Drug: Rabeprazole 10
RxNorm normalized name: RABEprazole 10 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 10 mg qd
Trial: 32488332
Drug: Rabeprazole 5
RxNorm normalized name: RABEprazole 5 mg oral delayed release capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 5 mg bid
Trial: 32488332
Drug: Rabeprazole 5
RxNorm normalized name: RABEprazole 5 mg oral delayed release capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 5 mg qd
Trial: 34341409
Drug: Intrauterine antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrauterine antibiotic infusion (IAI) combined with oral antibiotic administration (OAA)
Trial: 34341409
Drug: Oral antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antibiotic administration (OAA)
Trial: 34341409
Drug: Intrauterine antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrauterine antibiotic infusion (IAI)
Trial: 32702468
Drug: Chlorpropamide–glibenclamide–basal insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpropamide–glibenclamide–basal insulin
Trial: 35833450
Drug: Palliative Medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palliative Medicine consultation within 24 hours
Trial: 39269606
Drug: Ketamine infusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine infusions
Trial: 32781360
Drug: PBMC-therapy (intrauterine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PBMC-therapy (intrauterine administration of autologous hCG-activated PBMCs)
Trial: 35349378
Drug: Hormone contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone contraceptives
Trial: 34016410
Drug: Ranger drug‐coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranger drug‐coated balloon (DCB) (paclitaxel dose density 2 μg/mm2)
Trial: 35943120
Drug: Ranger drug‐coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranger drug‐coated balloon (DCB)
Trial: 32882390
Drug: Upstream administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upstream administration of ticagrelor before angiography
Trial: 32882390
Drug: Downstream administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Downstream administration of ticagrelor or prasugrel after angiography
Trial: 35091845
Drug: Pharmacist-led pharmaceutical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist-led pharmaceutical care program
Trial: 33407845
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment plus oxygen (Control)
Trial: 34344494
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care (vitamin K antagonist and low molecular weight heparin)
Trial: 34283841
Drug: Iron-containing micronutrient
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron-containing micronutrient powder (12.5 mg of iron daily)
Trial: 34475094
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of serum CEA, CKS2, OAS2, and ATG5
Trial: 32469454
Drug: PCIT-ED (Parent-Child
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCIT-ED (Parent-Child Interaction Therapy Emotion Development)
Trial: 35510723
Drug: Tablet personal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet personal computer distraction (animated video played during IV placement)
Trial: 35510723
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no tablet distraction)
Trial: 33675755
Drug: Monthly pegcetacoplan
RxNorm normalized name: Pegcetacoplan
DrugBank: Pegcetacoplan (DB16694)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly pegcetacoplan (15 mg)
Trial: 33675755
Drug: Every other
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Every other month (EOM) pegcetacoplan (15 mg)
Trial: 35115017
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual in clinics
Trial: 36048348
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of daily injectable vitamin B12
Trial: 36048348
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of daily injectable vitamin B12 with other multinutrients (B12 + MV)
Trial: 32493052
Drug: Intravenous continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous continuous infusion (CI) of midazolam
Trial: 32493052
Drug: Intravenous intermittent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous intermittent bolus (IB) doses of midazolam
Trial: 36197264
Drug: Medication combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication combined with schedule exercise therapy (MSET)
Trial: 38654329
Drug: Problem-solving therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem-solving therapy (PST)
Trial: 38061553
Drug: Supportive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive therapy (ST)
Trial: 32272181
Drug: Thymoquinone (TQ)
RxNorm normalized name: Hydroquinone
DrugBank: Thymoquinone (DB16447)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thymoquinone (TQ) alone or in combination
Trial: 33709982
Drug: Antihypertensive therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive therapies
Trial: 32951743
Drug: δ‐tocotrienol 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: δ‐tocotrienol 300 mg twice daily
Trial: 38734138
Drug: Oral treatment
RxNorm normalized name: Other agents for local oral treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral treatment
Trial: 33227785
Drug: Panic Control
RxNorm normalized name: BENZALKONIUM CHLORIDE 1 g in 59 mL TOPICAL GEL [Donut Panic Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Panic Control Treatment (PCT)
Trial: 33070253
Drug: Denosumab (specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab (specific antibody to human RANKL)
Trial: 34662890
Drug: Apixaban (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apixaban (2.5 mg twice daily, later increased to 5 mg twice daily)
Trial: 34662890
Drug: Warfarin (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (target international normalized ratio 2-3)
Trial: 34444833
Drug: Metformin (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (up to 2000 mg daily)
Trial: 32611451
Drug: High intensity,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High intensity, high frequency peer reminders (monthly)
Trial: 32611451
Drug: Monthly paper-based
RxNorm normalized name: paper birch pollen extract
DrugBank: Betula papyrifera pollen (DB10831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly paper-based reminders
Trial: 32000828
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg aspirin for 6 months after index ERBD
Trial: 35443676
Drug: DF-HA 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DF-HA 30 mg
Trial: 33367782
Drug: Ketone monoester
RxNorm normalized name: Ketonal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketone monoester (KME) drink containing 12 g β‐OHB
Trial: 36219198
Drug: Furocyst® (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furocyst® (2 capsules of 500 mg/day)
Trial: 35440463
Drug: Fit-For-Fertility Programme
RxNorm normalized name: Immunoglobulin G4, anti-programmed cell death protein 1 (PDCD1) (humanized clone ABT1 gamma4-chain), disulfide with humanized clone ABT1 kappa-chain, dimer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fit-For-Fertility Programme (FFFP) for 6 months, then in combination with usual care for infertility if not pregnant; intervention duration up to 18 months or 24 months if pregnant.
Trial: 34331930
Drug: Sublingual sufentanil
RxNorm normalized name: sufentanil Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual sufentanil cartridges (Zalviso)
Trial: 34331930
Drug: Intravenous pain
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous pain management (Control)
Trial: 33870785
Drug: Home-based Pilates
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based Pilates (twice-weekly, guided by a DVD)
Trial: 33667420
Drug: R-MegaCHOEP (high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-MegaCHOEP (high-dose chemotherapy plus rituximab followed by autologous HSCT)
Trial: 33667420
Drug: R-CHOEP-14 (conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-CHOEP-14 (conventional chemotherapy plus rituximab)
Trial: 33429762
Drug: Dexmedetomidine 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 0.2 μg/kg/hour (group D1)
Trial: 33429762
Drug: Dexmedetomidine 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 0.4 μg/kg/hour (group D2)
Trial: 33429762
Drug: 0.9% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% saline 0.2 μg/kg/hour (group C)
Trial: 36303659
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral contraceptives (COC)
Trial: 33469090
Drug: Silicon (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silicon (2.5 mM) added to nutrient solution
Trial: 33526397
Drug: Topical Vancomycin
RxNorm normalized name: Vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical Vancomycin Powder and Dilute Povidone-Iodine (VIP) protocol
Trial: 32240909
Drug: Short-course radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-course radiotherapy (SCRT) followed by chemotherapy (6 cycles CAPOX or 9 cycles FOLFOX4)
Trial: 32240909
Drug: Long-course radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-course radiotherapy (25-28 × 2-1.8 Gy) with concomitant capecitabine followed by surgery and optional postoperative chemotherapy (8 cycles CAPOX or 12 cycles FOLFOX4)
Trial: 36190481
Drug: 20,000 IU/10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20,000 IU/10 d (standard dose)
Trial: 36190481
Drug: 60,000 IU/10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60,000 IU/10 d (high dose)
Trial: 35214798
Drug: ShigETEC vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ShigETEC vaccine (5 × 10^10 colony forming units)
Trial: 35214798
Drug: ShigETEC vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ShigETEC vaccine
Trial: 33081606
Drug: Fluticasone furoate/vilanterol
RxNorm normalized name: fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone furoate/vilanterol (FF/VI) 100 µg/25 µg
Trial: 35584932
Drug: Prasugrel single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel single antiplatelet therapy (SAPT) after short-term dual antiplatelet therapy (DAPT)
Trial: 36861447
Drug: Platinum-containing chemotherapy
RxNorm normalized name: platinum
DrugBank: Platinum (DB12257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platinum-containing chemotherapy
Trial: 33526434
Drug: telephone cognitive-behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: telephone cognitive-behavioural therapy (tCBT)
Trial: 32040141
Drug: Outpatient integrated
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Outpatient integrated palliative care (PC) administered by a neurologist, social worker, chaplain, and nurse.
Trial: 34151672
Drug: Drug Coated
RxNorm normalized name: Drug coated stent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug Coated Balloon (DCB) (Paclitaxel)
Trial: 36102219
Drug: Maternal metabolic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maternal metabolic parameters (fasting glucose, insulin, HOMA-IR, leptin)
Trial: 34676743
Drug: Conventional i-gel
RxNorm normalized name: iobenguane I-131
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional i-gel insertion
Trial: 32609011
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II therapy
Trial: 34147116
Drug: Caffeinated chewing
RxNorm normalized name: caffeine Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeinated chewing gum (5.4 mg/kg)
Trial: 34147116
Drug: Caffeinated chewing
RxNorm normalized name: caffeine Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeinated chewing gum (2.7 mg/kg)
Trial: 35589595
Drug: Aspirin combined
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin combined with clopidogrel
Trial: 33620407
Drug: Baclofen (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen (50 to 150 mg per day)
Trial: 32611648
Drug: Adavosertib (225
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adavosertib (225 mg twice daily for 2.5 days/21-day cycle) plus carboplatin (AUC5) and paclitaxel (175 mg/m2)
Trial: 32611648
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus carboplatin (AUC5) and paclitaxel (175 mg/m2)
Trial: 33238961
Drug: propolis 100
RxNorm normalized name: propolis
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: propolis 100 µg/ml (P100)
Trial: 33238961
Drug: propolis 250
RxNorm normalized name: propolis
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: propolis 250 µg/ml (P250)
Trial: 33238961
Drug: chitosan-propolis nanoparticle
RxNorm normalized name: Chitosan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: chitosan-propolis nanoparticle 100 µg/ml (CPN100)
Trial: 33238961
Drug: chitosan-propolis nanoparticle
RxNorm normalized name: Chitosan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: chitosan-propolis nanoparticle 250 µg/ml (CPN250)
Trial: 35426733
Drug: Yoga program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoga program (75-min classes, twice weekly for 4 weeks, then once a week for 8 weeks, total 16 classes)
Trial: 35426733
Drug: Educational film
RxNorm normalized name: DIABETES PATIENT EDUCATION PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Educational film program (75-min classes, once weekly for 12 weeks, total 12 classes)
Trial: 32565388
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus Denosumab (120 mg every 3–4 weeks)
Trial: 36180619
Drug: Perioperative oral
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Perioperative oral immunonutrition
Trial: 34422262
Drug: 40 g
RxNorm normalized name: PEG-40 GLYCERYL STEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 g sucrose in 500 ml water
Trial: 34422262
Drug: 80 g
RxNorm normalized name: PEG-80 GLYCERYL COCOATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 g sucrose in 500 ml water
Trial: 34422262
Drug: 120 g
RxNorm normalized name: soap 120 gram TOPICAL BAR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 g sucrose in 500 ml water
Trial: 34863879
Drug: Zataria multiflora
RxNorm normalized name: Reynoutria multiflora root oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zataria multiflora 5 mg/kg/day (Z5)
Trial: 34863879
Drug: Zataria multiflora
RxNorm normalized name: Reynoutria multiflora root oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zataria multiflora 10 mg/kg/day (Z10)
Trial: 35675902
Drug: Sevoflurane anesthesia
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevoflurane anesthesia with morphine (10 mg/kg) (MACSEVO+MOR)
Trial: 32100031
Drug: Oral antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antibiotics given to children
Trial: 32100031
Drug: Antibiotic use
RxNorm normalized name: Antibiotics for systemic use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic use among children
Trial: 32100031
Drug: Average number
RxNorm normalized name: Derma Numb
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Average number of antibiotic courses per child
Trial: 32100031
Drug: Antibiotics given
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics given without a prescription
Trial: 32100031
Drug: Parental knowledge
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parental knowledge of antibiotic indications
Trial: 35383339
Drug: 5 mg/day
RxNorm normalized name: Lyllana 0.05 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/day folate supplements
Trial: 35435877
Drug: Mindfulness-based breathing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-based breathing and music therapy
Trial: 32932009
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment and care (Control group, n=30)
Trial: 34247893
Drug: Laser-cane with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser-cane with 15-min walking training and 15-min traditional physical therapy (EG)
Trial: 35222899
Drug: Multidisciplinary combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidisciplinary combined nondrug therapy
Trial: 35222899
Drug: Conventional conservative
RxNorm normalized name: Conserved dopamine neurotrophic factor
DrugBank: HER-902 (DB17948)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional conservative treatment (control group)
Trial: 32822614
Drug: Sildenafil (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (20 mg three times daily) added to pirfenidone (801 mg three times daily)
Trial: 32822614
Drug: Placebo added
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo added to pirfenidone (801 mg three times daily)
Trial: 35799106
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Group C) - PCA drugs only in the constant flow chamber with normal saline in the adjustable flow chamber
Trial: 32951121
Drug: Passiflora incarnata
RxNorm normalized name: Passiflora incarnata
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Passiflora incarnata (500 mg)
Trial: 32951121
Drug: Erythrina mulungu
RxNorm normalized name: Erythrina variegata bark extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythrina mulungu (500 mg)
Trial: 35428324
Drug: Baihu and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baihu and Guizhi decoction (BHGZ) plus low-dose colchicine
Trial: 35428324
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus low-dose colchicine
Trial: 33475705
Drug: Irinotecan monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irinotecan monotherapy
Trial: 35995058
Drug: Face-to-Face (F2F)
RxNorm normalized name: FACE SHIELD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Face-to-Face (F2F) therapy
Trial: 36138055
Drug: Sham therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham therapy (placebo needles)
Trial: 32896504
Drug: Hormone group
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone group (3‐day, low‐dose glucocorticoid treatment plus conventional treatment; 63 patients)
Trial: 32896504
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (conventional treatment only; 62 patients)